Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.42 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4027923 | 0.91 | ADRA2A (0.42) | CA2CA1ENPP2TTRTSHR | |
| SCHEMBL442154 | 0.91 | ALDH1A1 (0.45) | CA2CA1ENPP2TTRALDH1A1 | |
| SCHEMBL29956883 | 0.91 | ALDH1A1 (0.45) | CA2CA1ENPP2TTRALDH1A1 | |
| SCHEMBL8569648 | 0.83 | DRD1 (0.50) | — | |
| SCHEMBL13356016 | 0.82 | CA1 (0.34) | CA2CA1ENPP2TTR | |
| SCHEMBL20968620 | 0.82 | CA2 (0.34) | CA2CA1ENPP2MGLLTTR | |
| SCHEMBL21974802 | 0.82 | CYP2A6 (0.48) | CA2CA1ENPP2MGLLTTR | |
| SCHEMBL3101723 | 0.78 | NPC1 (0.42) | CA2CA1ENPP2MGLLTTR | |
| SCHEMBL15329663 | 0.78 | ASIC3 (0.55) | — | |
| SCHEMBL29953828 | 0.78 | ENPP2 (0.35) | CA2CA1ENPP2TTRTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3822278-B1 | ELECTRON-ACCEPTING COMPOUND, COMPOSITION FOR CHARGE TRANSPORT FILM, AND LIGHT-EMITTING ELEMENT USING SAME | MITSUBISHI CHEM CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4382516-B1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | LG CHEMICAL LTD (KR) | 2025-10-29 | — | — | EP | disclosed |
| EP-4403554-B1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | LG CHEMICAL LTD (KR) | 2025-09-24 | — | — | EP | disclosed |
| US-20240409493-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2024-12-12 | — | — | US | disclosed |
| US-20240407256-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| EP-4403554-A1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | LG Chem, Ltd. (KR) | 2024-07-24 | — | — | EP | disclosed |
| EP-4382516-A1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | LG Chem, Ltd. (KR) | 2024-06-12 | — | — | EP | disclosed |
| CN-117980301-A | Compound, coating composition comprising the same, organic light emitting device using the same, and method for manufacturing the same | 株式会社LG化学 | 2024-05-03 | — | — | CN | disclosed |
| CN-117957216-A | Compound, coating composition comprising the same, organic light emitting device using the same, and method for manufacturing the same | 株式会社LG化学 | 2024-04-30 | — | — | CN | disclosed |
| US-11793069-B2 | Electron-accepting compound and composition for charge-transporting film, and luminescent element using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20150191494-A1 | TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR | ALBANY MOLECULAR RESEARCH, INC. | 2015-07-09 | — | — | US | disclosed |
| EP-2770006-A1 | CROSS-LINKING POLYMER AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-20140231771-A1 | CROSS-LINKING POLYMER AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. | 2014-08-21 | — | — | US | disclosed |
| US-20140231771-A1 | CROSS-LINKING POLYMER AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. | 2014-08-21 | — | — | US | disclosed |
| US-8420811-B2 | Tetrahydroisoquinolines and intermediates therefor | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-16 | — | — | US | disclosed |
| US-8420811-B2 | Tetrahydroisoquinolines and intermediates therefor | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-16 | — | — | US | disclosed |
| US-20130060027-A1 | TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130060027-A1 | TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-03-07 | — | — | US | disclosed |
| US-20110077400-A1 | PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES | Bristol-Myers Squibb Company and Albany Molecular Research, Inc | 2011-03-31 | — | — | US | disclosed |
| US-20110077400-A1 | PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES | Bristol-Myers Squibb Company and Albany Molecular Research, Inc | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130060027-A1 | TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR | FARS2, TPH1, COQ8A | CA2 4184/4885CA1 3329/4885ENPP2 2791/4885 |
| US-20150191494-A1 | TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR | FARS2, TPH1, COQ8A | CA2 4184/4885CA1 3329/4885ENPP2 2791/4885 |
| US-11793069-B2 | Electron-accepting compound and composition for charge-transporting film, and luminescent element using same | SLC26A3, SLC6A19, SLC29A1 | CA2 1506/4885CA1 1775/4885ENPP2 2549/4885 |
| US-20110077400-A1 | PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES | HTR2C, HTR3B, TPH2 | CA2 3926/4885CA1 2450/4885ENPP2 2765/4885 |
| US-20240409493-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | NOTUM, SEM1, OR51E2 | CA2 4314/4885CA1 2087/4885ENPP2 4122/4885 |
| US-20240407256-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | NOTUM, ORMDL3, SEM1 | CA2 4499/4885CA1 2435/4885ENPP2 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.